Back to Journals » Drug Design, Development and Therapy » Volume 2

Submucosal injection solution for gastrointestinal tract endoscopic mucosal resection and endoscopic submucosal dissection

Authors Uraoka T, Saito Y, Yamamoto K, Fujii T

Published 11 August 2008 Volume 2008:2 Pages 131—138


Review by Single anonymous peer review

Peer reviewer comments 3

Toshio Uraoka1, Yutaka Saito2, Kazuhide Yamamoto1, Takahiro Fujii3

1Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; 2Division of Endoscopy, National Cancer Center Hospital, Tokyo, Japan; 3TF Clinic, Tokyo, Japan

Abstract: Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) have provided new alternatives for minimally invasive treatment of gastrointestinal adenomas and early-stage cancers that involve a minimum risk of lymph-node metastasis. The use of submucosal injections is essential to the success of these endoscopic resection techniques. The “ideal” submucosal injection solution should provide a sufficiently high submucosal fluid cushion for safe and effective EMRs and ESDs while also preserving lesion tissue for accurate histopathological assessment. In the past, normal saline (NS) solution was commonly used for this purpose, but it is difficult to achieve the proper submucosal elevation and maintain the desired height with NS. Therefore, other safe and effective facilitative submucosal injection solutions have been developed that also take into account relevant cost-benefit considerations. This review examines recent advances in the development of effective submucosal injection solutions for use during endoscopic resections.

Keywords: submucosal injection solution, endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), gastrointestinal tract

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]